Curie Cancer : the launch of biotechnology company Honing Biosciences

Institut Curie (Curie Cancer Carnot Institute) announces the launch of biotechnology company Honing Biosciences, a technology platform that develops solutions to optimize the efficiency and safety of cell therapies in cancer and chronic diseases.

Cell-based therapy modify and use the cells to restore the function of a tissue or organ or to cure a disease. The goal is to provide long-term care for cancer patients through a single injection of therapeutic cells.

Honing Biosciences relies on proprietary technologies that enable precise control of cellular functions, providing a unique answer to current limitations.

More details